T1	Treatment 20 56	nanocrystalline hydroxyapatite paste
T2	Treatment 330 393	nanocrystalline hydroxyapatite (nano-HA) bone graft substitute.
T3	Treatment 541 672	were randomly selected to receive nano-HA paste in conjunction with papilla preservation flaps or papilla preservation flaps alone.
T4	Treatment 673 825	Probing bone levels (PBL) from a customized acrylic stent and probing pocket depths (PPD) were measured at baseline and again 6 months following surgery
T5	Treatment 1110 1128	with nano-HA paste
T6	Treatment 1637 1676	compared with papilla preservation flap
